Citadel Security Services to Distribute American Bio Medica Drug Testing Products; Agreement Opens New Opportunities in Workplace and Criminal Justice Markets.

Business Editors

KINDERHOOK, N.Y.--(BUSINESS WIRE)--Nov. 6, 2001

American Bio Medica Corporation (NASDAQ: ABMC) today announced it had entered a distribution relationship with Citadel Security Services (CSS), a leading supplier of state-of-the-art drug testing products and services to workplace, criminal justice, drug treatment, and school programs throughout the country.

The agreement includes a variety of ABMC on-site drug testing products.

Established four years ago by former National Football League players Mike Chalenski and Danny Stubbs, CSS has experienced exponential growth by specializing in fast and confidential drug testing services. The company is headquartered in Haddonfield, New Jersey; it operates a southeast division headquarters in Boca Raton, Florida. The company's web address is www.csstest.com.

"We've been able to establish ourselves and grow in this business by offering the newest and most innovative products, and ABMC is a perfect fit for us in that regard," said Chalenski, who is president of CSS. "The ABMC technologies stand apart in terms of reliability and on-site performance at a reasonable price. And we are especially enthusiastic about the service relationship we are already building between our two companies."

ABMC president and chief executive officer Robert L. Aromando Jr. explained that the agreement with CSS is a strengthening of its distribution strategy.

"We have said throughout the past several months that we are committed to creating and building distribution partnerships with major players who can make an immediate impact in key markets," said Aromando. "CSS is a dynamic company, and we know they can leverage our products in key situations, especially in the workplace and criminal justice markets."

About American Bio Medica Corporation

American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate on-site drugs-of-abuse diagnostic kits, sprays and support services worldwide. The company's global distributors target the workplace, physicians, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(TM) and OralStat-6(TM) test for the presence or absence of drugs of abuse in urine and saliva respectively while its Drug Detector(TM) identifies minute traces of illegal drugs on surfaces.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.